Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Set aside
We asked nutritionists Some food companies, including Nestle and Conagra, are responding to the popularity of obesity and diabetes drugs by branding some products "GLP-1 Friendly." The labels target a growing number of consumers taking medicines such as Zepbound and Wegovy who may be looking for healthier, ready-made meals that minimize side-effects from the drugs
1 Noom notes that there are three essential hurdles that are hindering progress along this front: The cost of medication The sides effects of medication An absence of sustainable behavior change In fact, among patients who begin utilizing GLP-1s, over 50% of them stop as a result of cost, while 36% stop because of side effects
Results: Of the 63 patients, the mean age was 49 years, 65% were male, 17% were cirrhotic, 67% were treated with ETV, and the median treatment duration was 3 years
US$ 24.45
US$ 20.71
US$ 25.85
